Moneycontrol PRO
HomeNewsTrendsHealthCoronavirus Daily Update: COVID-19 cases explained in charts

Coronavirus Daily Update: COVID-19 cases explained in charts

Despite the high number of cases and deaths reported by India, the country has fared better when compared to other nations in terms of per million population.

January 04, 2021 / 11:25 IST

As many as 16,504 new COVID-19 cases were reported in the previous 24 hours, taking India’s overall tally to 1.03 crore, according to the health ministry’s latest update on January 4.

India reported 214 deaths (below the 300 mark for the 10th day in a row) and 19,557 recoveries in the previous 24 hours, data shows. Active cases continued to drop, to 2.43 lakh with a fall of 3,267 cases in a day.

Kerala reported the most (4,600 or 28 percent) new cases in the last 24 hours, followed by Maharashtra (3,282), West Bengal (896), Tamil Nadu (867) and Karnataka (810). These five states accounted for 63 percent of all the new cases reported in India. Fifteen states are now reporting less than 100 new cases.

Follow our LIVE blog for the latest updates of the coronavirus pandemic

2021-covid-19-update-Jan4_2

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

Maharashtra reported the most deaths in a day (35), followed by West Bengal (26), Kerala (25) and Uttar Pradesh (16). These four states accounted for 48 percent of all the new deaths reported across the country.

About 11 states and Union Territories like Andaman and Nicobar, Arunachal Pradesh, Dadra and Nagar Haveli/Daman and Diu, Ladakh, Meghalaya, Mizoram, Nagaland, Pudduchery, Sikkim and Tripura did not report any deaths during this period.

India’s recovery rate now stands at 96.2 percent. While Dadra Nagar Haveli/Daman & Diu has the highest recovery rate (99.7 percent), Sikkim now reports the lowest (89.3 percent). In terms of cases, Kerala recorded 4,668 new recoveries in a day, the most, followed by Maharashtra (2,064), West Bengal (1,432), Chhattisgarh (1,237) and Uttar Pradesh (1,179).

2021-covid-19-update-Jan4

The total number of COVID-19 cases in India reached 1,03,40,469 (1.03 crore) with 99,46,867 recoveries and 1,49,649 deaths. The mortality rate in the country stood at 1.4 percent with Punjab reporting the highest (3.2 percent). Less than 7.5 lakh daily tests were reported on January 3 with more than 17.56 crore tests carried out till date.

2021-covid-19-update-Jan4_1

Despite the high number of cases and deaths reported by India, the country fares better when compared with other nations in terms of per million population.

Click here for Moneycontrol’s full coverage of the coronavirus pandemic

On January 3, the Drugs Controller General of India (DCGI) granted restricted emergency use authorisation for the Serum Institute of India (SII)’s ‘Covishield’ and Bharat Biotech’s ‘Covaxin’ vaccines against COVID-19, the disease caused by the novel coronavirus.

COVID-19 Vaccine Tracker: What you need to know about manufacturing and pricing

Chaitanya Mallapur
first published: Jan 4, 2021 11:23 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347
CloseOutskill Genai